To complicate matters, the reviewing pathologist reclassifies the tumor as a typical lobular carcinoma (not pleomorphic), but the receptor study profiles (ER, PR) and Her-2/neu status remain unchanged. The gene discussed is PGR; the disease is neoplasm.